Abstract

315 Background: Mobile apps (MA) can be useful resources to provide point of care information. Over 50% of patients use a smartphone (SP), 75% of North American physicians own a SP, and 58% of SP users have downloaded mobile MA. MA are more readily accessible than web-based tools and usable without network connectivity. Methods: Cancer Care Ontario (CCO) has developed MA for patients and providers using the principles of end user satisfaction, simplicity and intuitiveness. These MA are taken from established web based, validated educational modules. Designed to ensure a rich native experience for each platform (WP7 and iOS), CCO’s process includes proof of concept, information design, and user interface design supported by user acceptance testing. Results: Two MA have been created: “CCO Drug Formulary” and “CCO Symptom Management Guidelines Application”. The first MA provides information on both drugs and regimens used in cancer treatment for patients and providers through alternate navigation in the same MA. From launch in October 2011 until June 2012, the Drug Formulary app had 4,280 downloads, including 39% from Asia and 14% from Europe, suggesting a global market. The second app provides symptom management guidelines for providers, hence supporting clinical decision making at point of care. From January 2011 to June 2012, the Symptom Management Guidelines MA had 4,050 downloads, in a mainly North American market. Both patient and provider feedback on preliminary evaluation has been positive. Conclusions: Patients and providers are receptive to MA as a tool to deliver real-time information at point of care. MA are another interface to existing technology solutions and other rich data sources. Further research into patient outcomes from adoption of such technology is needed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call